DD154098A5 - Verfahren zur herstellung neuer acylpeptide - Google Patents

Verfahren zur herstellung neuer acylpeptide Download PDF

Info

Publication number
DD154098A5
DD154098A5 DD80225932A DD22593280A DD154098A5 DD 154098 A5 DD154098 A5 DD 154098A5 DD 80225932 A DD80225932 A DD 80225932A DD 22593280 A DD22593280 A DD 22593280A DD 154098 A5 DD154098 A5 DD 154098A5
Authority
DD
German Democratic Republic
Prior art keywords
trp
phe
cys
amino
formula
Prior art date
Application number
DD80225932A
Other languages
German (de)
English (en)
Inventor
Hans Rink
Peter Sieber
Bruno Kamber
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD154098A5 publication Critical patent/DD154098A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DD80225932A 1979-12-14 1980-12-10 Verfahren zur herstellung neuer acylpeptide DD154098A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1109679 1979-12-14

Publications (1)

Publication Number Publication Date
DD154098A5 true DD154098A5 (de) 1982-02-24

Family

ID=4370005

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80225932A DD154098A5 (de) 1979-12-14 1980-12-10 Verfahren zur herstellung neuer acylpeptide

Country Status (18)

Country Link
US (1) US4369179A (fi)
EP (1) EP0030920B1 (fi)
JP (1) JPS5692850A (fi)
KR (2) KR850000415B1 (fi)
AT (1) ATE6251T1 (fi)
AU (1) AU544256B2 (fi)
CA (1) CA1161033A (fi)
DD (1) DD154098A5 (fi)
DE (1) DE3066654D1 (fi)
DK (1) DK532180A (fi)
ES (1) ES497696A0 (fi)
FI (1) FI803849L (fi)
GR (1) GR73621B (fi)
IL (1) IL61696A0 (fi)
NO (1) NO803757L (fi)
NZ (1) NZ195817A (fi)
PT (1) PT72191B (fi)
ZA (1) ZA807796B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE14226T1 (de) * 1981-12-24 1985-07-15 Ciba Geigy Ag Cyclische octapeptide und pharmazeutische praeparate davon, sowie verfahren zur herstellung derselben und ihre anwendung.
FR2522655B1 (fr) * 1982-03-05 1987-03-06 Sanofi Sa Analogues de la somatostatine possedant une liaison du type hydrazide et medicaments en contenant
EP0113029B1 (en) * 1982-12-06 1989-04-19 Merck & Co. Inc. Dicyclic hexapeptides, processes for their preparation and pharmaceutical compositions containing them
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
JP2882679B2 (ja) * 1989-04-26 1999-04-12 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 線状ソマトスタチン類似体
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5905140A (en) * 1996-07-11 1999-05-18 Novo Nordisk A/S, Novo Alle Selective acylation method
US6355613B1 (en) * 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
EP0981364B1 (en) * 1997-05-13 2006-03-01 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Method and compositions for treating hyperlipidemia
AU7655098A (en) 1997-05-13 1998-12-08 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Somatostatin and somatostatin agonists for decreasing body weight
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
ES2216290T3 (es) * 1997-05-13 2004-10-16 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatina y agonistas de la somatostatina para el tratamiento de insensibilidad a la insulina y de sindrome x.
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
BR0113178A (pt) * 2000-08-02 2004-04-06 Theratechnologies Inc Peptìdeos biológicos modificados com potência aumentada
PT2062914E (pt) 2001-06-08 2014-07-18 Ipsen Pharma Sas Análogos quiméricos de somatostatina-dopamina
EP2161037A3 (en) 2003-04-22 2010-05-26 Ipsen Pharma Camptothecin-Somatostatin conjugates
US10240138B2 (en) 2008-06-12 2019-03-26 Ipsen Bioinnovation Limited Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
US20110171191A1 (en) 2008-06-12 2011-07-14 Syntaxin Limited Suppression of neuroendocrine diseases
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
JP6869720B2 (ja) 2013-06-13 2021-05-12 アンチセンス セラピューティクス リミテッド 併用療法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875207A (en) * 1967-01-25 1975-04-01 Ciba Geigy Corp Process for the temporary protection of amino groups in peptide syntheses
US3944590A (en) * 1967-01-25 1976-03-16 Ciba-Geigy Corporation Process for the temporary protection of amino groups in peptide syntheses
US3725380A (en) * 1969-04-05 1973-04-03 Hoechst Ag Method of synthesizing peptides in the presence of a carbodiimide and a 1-hydroxy-benzotriazole
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
DE2202613C3 (de) * 1972-01-20 1974-06-20 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Verfahren zur Herstellung von Peptiden
CH577464A5 (fi) * 1972-09-22 1976-07-15 Ciba Geigy Ag
US3882098A (en) * 1974-01-03 1975-05-06 American Home Prod Synthesis of des-Ala{hu 1{b , Gly{hu 2{b , Asn{hu 5{b -SRIF and intermediates
US4113714A (en) * 1975-01-03 1978-09-12 American Home Products Corporation [Des-Ala1, Gly2 -desamino-Cys3 ]somatostatin
US4130554A (en) * 1975-04-08 1978-12-19 Merck & Co., Inc. Process for preparing somatostatin analog
US4000259A (en) * 1975-06-16 1976-12-28 American Home Products Corporation Cyclic dodecapeptide analogs of somatostatin and intermediates
US3988304A (en) * 1975-08-25 1976-10-26 American Home Products Corporation Cyclic dodecapeptide derivatives of somatostatin and intermediates thereof
CA1083143A (en) * 1976-01-02 1980-08-05 Nedumparambil A. Abraham Carba derivatives of somatostatin and process therefor
US4062816A (en) * 1976-03-11 1977-12-13 Eli Lilly And Company D-Ala5 -somatostatin and intermediates thereto
US4098782A (en) * 1977-03-14 1978-07-04 American Home Products Corporation (His5)-somatostatin and analogues thereof
US4118380A (en) * 1977-07-25 1978-10-03 Ayerst, Mckenna & Harrison Limited Decapeptide analogs of somatostatin
US4115554A (en) * 1977-08-29 1978-09-19 Merck & Co., Inc. Somatostatin analogs
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4140767A (en) * 1977-12-01 1979-02-20 Merck & Co., Inc. Somatostatin analogs
US4202802A (en) * 1978-10-02 1980-05-13 Eli Lilly And Company Peptides related to somatostatin
US4191754A (en) * 1979-02-28 1980-03-04 Merck & Co., Inc. Bicyclic somatostatin analogs
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs

Also Published As

Publication number Publication date
EP0030920A3 (en) 1981-11-04
AU544256B2 (en) 1985-05-23
KR850000414B1 (ko) 1985-03-26
ZA807796B (en) 1982-01-27
ATE6251T1 (de) 1984-03-15
ES8200861A1 (es) 1981-11-16
IL61696A0 (en) 1981-01-30
DK532180A (da) 1981-06-15
NO803757L (no) 1981-06-15
FI803849L (fi) 1981-06-15
GR73621B (fi) 1984-03-26
AU6534580A (en) 1981-06-18
DE3066654D1 (en) 1984-03-22
PT72191A (de) 1981-01-01
US4369179A (en) 1983-01-18
KR850000415B1 (ko) 1985-03-26
ES497696A0 (es) 1981-11-16
KR830004216A (ko) 1983-07-06
EP0030920A2 (de) 1981-06-24
NZ195817A (en) 1984-07-06
JPS5692850A (en) 1981-07-27
EP0030920B1 (de) 1984-02-15
CA1161033A (en) 1984-01-24
PT72191B (de) 1982-01-13

Similar Documents

Publication Publication Date Title
EP0030920B1 (de) Acylpeptide und pharmazeutische Präparate davon, sowie deren Herstellung und Verwendung
EP0023192B1 (de) Cyclopeptide und pharmazeutische Präparate davon, sowie Verfahren zu ihrer Herstellung und deren Anwendung
EP0001295B1 (de) Somatostatin-analoge Cyclopeptide, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Anwendung
EP0083305B1 (de) Cyclische Octapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung
EP0031303A2 (de) Cyclooctapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung
EP0017760B1 (de) Somatostatin-analoge Peptide, ihre Herstellung und Verwendung, sie enthaltende pharmazeutische Präparate und deren Herstellung
DE3333640A1 (de) Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DE3686099T2 (de) Analoga von cyclischen hexapeptiden von somatostatin, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE2635558A1 (de) Somatostatinanaloge
DD153684A5 (de) Verfahren zur herstellung von cyclischen hexapeptid-somatostatin-analogen
DE2831534C2 (de) Octapeptide, Verfahren zu ihrer Herstellung und diese Octapeptide enthaltende Angiotensin-II-antagonistisch wirkende Arzneimittel
EP0117447B1 (de) Cyclische Peptide mit Somatostatin-Wirkung
DE3328952A1 (de) Neue polypeptide, verfahren zu ihrer herstellung, pharmazeutische praeparate welche sie enthalten, sowie ihre verwendung
DE2901478A1 (de) Beta tief h -endorphin-analoge und deren herstellung
DE2423549A1 (de) Verfahren zur herstellung von cystinhaltigen peptiden
DE3312399A1 (de) Biologisch aktive peptide und arzneimittel, welche diese enthalten
DE3537405A1 (de) Biologisch aktive penta- und heptapeptide, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
CH628323A5 (de) Verfahren zur herstellung von cholecystokinin-pancreozymin-octapeptidamid-sulfatester.
DE2807403A1 (de) Peptidderivate des somatostatins, verfahren zu ihrer herstellung, arzneimittel und zwischenprodukte
DE2327634A1 (de) Nonapeptide und verfahren zu deren herstellung
DE3625175A1 (de) Somatostatin-derivate
DD139125B1 (de) Verfahren zur herstellung von undekapeptiden
DE2209835B2 (de) Insulinderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DD272227A1 (de) Verfahren zur herstellung herzwirksamer praeparate auf peptidbasis
DE3518086A1 (de) Biologisch aktive tridecapeptide, verfahren zu deren herstellung und mittel, die diese enthalten